Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
61 |
Material Type: Article
|
![]() |
Priorities for cancer research in low- and middle-income countries: a global perspectiveNature medicine, 2022-04, Vol.28 (4), p.649-657 [Peer Reviewed Journal]2022. Springer Nature America, Inc. ;Springer Nature America, Inc. 2022. ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-022-01738-x ;PMID: 35440716Full text available |
62 |
Material Type: Article
|
![]() |
Women in contemporary cancer researchInternational journal of cancer, 2020-09, Vol.147 (6), p.1571 [Peer Reviewed Journal]2020 UICC. ;EISSN: 1097-0215 ;DOI: 10.1002/ijc.32938 ;PMID: 32086947Digital Resources/Online E-Resources |
63 |
Material Type: Article
|
![]() |
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysisThe Lancet (British edition), 2012-03, Vol.379 (9822), p.1214-1224 [Peer Reviewed Journal]Elsevier Ltd ;2012 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Mar 31-Apr 6, 2012 ;2012 Elsevier Ltd. All rights reserved. 2012 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(12)60110-X ;PMID: 22421340 ;CODEN: LANCAOFull text available |
64 |
Material Type: Article
|
![]() |
Cuts in cancer research funding due to COVID-19The lancet oncology, 2021-01, Vol.22 (1), p.e6-e6 [Peer Reviewed Journal]2021 Elsevier Ltd ;2021. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(20)30749-X ;PMID: 33341123Full text available |
65 |
Material Type: Article
|
![]() |
Realizing the Potential of Cancer Prevention — The Role of Implementation ScienceThe New England journal of medicine, 2017-03, Vol.376 (10), p.986-990 [Peer Reviewed Journal]Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMsb1609101 ;PMID: 28273020Full text available |
66 |
Material Type: Article
|
![]() |
Reframing the "Cancer Moonshot"EMBO reports, 2016-12, Vol.17 (12), p.1685-1687 [Peer Reviewed Journal]2016 The Author ;ISSN: 1469-221X ;EISSN: 1469-3178 ;DOI: 10.15252/embr.201643467 ;CODEN: ERMEAXFull text available |
67 |
Material Type: Article
|
![]() |
Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trialThe lancet oncology, 2021-08, Vol.22 (8), p.1162-1174 [Peer Reviewed Journal]2021 Elsevier Ltd ;2021. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(21)00302-8Full text available |
68 |
Material Type: Article
|
![]() |
Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cyclesThe Lancet (British edition), 2013-05, Vol.381 (9880), p.1817-1826 [Peer Reviewed Journal]Elsevier Ltd ;2013 Elsevier Ltd ;2014 INIST-CNRS ;Copyright © 2013 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited May 25, 2013 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(13)60313-X ;PMID: 23615461 ;CODEN: LANCAOFull text available |
69 |
Material Type: Article
|
![]() |
Global post-mortem tissue donation programmes to accelerate cancer researchNature reviews. Cancer, 2024-05, Vol.24 (5), p.289-290 [Peer Reviewed Journal]Springer Nature Limited 2024. ;ISSN: 1474-175X ;EISSN: 1474-1768 ;DOI: 10.1038/s41568-024-00683-w ;PMID: 38589555Digital Resources/Online E-Resources |
70 |
Material Type: Article
|
![]() |
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methodsInternational journal of cancer, 2019-04, Vol.144 (8), p.1941 [Peer Reviewed Journal]2018 UICC. ;EISSN: 1097-0215 ;DOI: 10.1002/ijc.31937 ;PMID: 30350310Digital Resources/Online E-Resources |
71 |
Material Type: Article
|
![]() |
Raise standards for preclinical cancer researchNature (London), 2012-03, Vol.483 (7391), p.531-533 [Peer Reviewed Journal]Copyright Nature Publishing Group Mar 29, 2012 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/483531a ;CODEN: NATUASFull text available |
72 |
Material Type: Article
|
![]() |
Big data in basic and translational cancer researchNature reviews. Cancer, 2022-11, Vol.22 (11), p.625-639 [Peer Reviewed Journal]This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;ISSN: 1474-175X ;EISSN: 1474-1768 ;DOI: 10.1038/s41568-022-00502-0 ;PMID: 36064595Full text available |
73 |
Material Type: Article
|
![]() |
Black voices in cancer research and oncologyNature reviews. Cancer, 2024-04, Vol.24 (4), p.235-239 [Peer Reviewed Journal]Springer Nature Limited 2024. ;ISSN: 1474-175X ;EISSN: 1474-1768 ;DOI: 10.1038/s41568-023-00662-7 ;PMID: 38374427Digital Resources/Online E-Resources |
74 |
Material Type: Article
|
![]() |
HIV-1 viremia not suppressible by antiretroviral therapy can originate from large T cell clones producing infectious virusThe Journal of clinical investigation, 2020-11, Vol.130 (11), p.5847-5857 [Peer Reviewed Journal]COPYRIGHT 2020 American Society for Clinical Investigation ;COPYRIGHT 2020 American Society for Clinical Investigation ;Copyright American Society for Clinical Investigation Nov 2020 ;2020 American Society for Clinical Investigation 2020 American Society for Clinical Investigation ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/JCI138099 ;PMID: 33016926Full text available |
75 |
Material Type: Article
|
![]() |
CRISPR in cancer biology and therapyNature reviews. Cancer, 2022-05, Vol.22 (5), p.259-279 [Peer Reviewed Journal]2022. Springer Nature Limited. ;Springer Nature Limited 2022. ;ISSN: 1474-175X ;EISSN: 1474-1768 ;DOI: 10.1038/s41568-022-00441-w ;PMID: 35194172Full text available |
76 |
Material Type: Article
|
![]() |
Global cancer research in the post-pandemic worldThe lancet oncology, 2021-12, Vol.22 (12), p.1652-1654 [Peer Reviewed Journal]2021 Elsevier Ltd ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(21)00602-1 ;PMID: 34856137Full text available |
77 |
Material Type: Article
|
![]() |
Monica Bertagnolli: Director of the National Institutes of HealthThe Lancet (British edition), 2024-02, Vol.403 (10427), p.605-605 [Peer Reviewed Journal]2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00262-9 ;PMID: 38368885Full text available |
78 |
Material Type: Article
|
![]() |
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trialThe Lancet (British edition), 2011-06, Vol.377 (9784), p.2181-2192 [Peer Reviewed Journal]Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 25-Jul 1, 2011 ;2011 Elsevier Ltd. All rights reserved. 2011 Elsevier Ltd ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(11)60739-3 ;PMID: 21663949 ;CODEN: LANCAOFull text available |
79 |
Material Type: Article
|
![]() |
A decade of immune-checkpoint inhibitors in cancer therapyNature communications, 2020-07, Vol.11 (1), p.3801-3801, Article 3801 [Peer Reviewed Journal]The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Distributed under a Creative Commons Attribution 4.0 International License ;The Author(s) 2020 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-020-17670-y ;PMID: 32732879Full text available |
80 |
Material Type: Article
|
![]() |
Publication Trends in Acupuncture Research: A 20-Year Bibliometric Analysis Based on PubMedPloS one, 2016-12, Vol.11 (12), p.e0168123-e0168123 [Peer Reviewed Journal]COPYRIGHT 2016 Public Library of Science ;COPYRIGHT 2016 Public Library of Science ;2016 Ma et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 Ma et al 2016 Ma et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0168123 ;PMID: 27973611Full text available |